home / stock / hchc / hchc news


HCHC News and Press, HC2 Holdings Inc. From 04/28/20

Stock Information

Company Name: HC2 Holdings Inc.
Stock Symbol: HCHC
Market: NYSE
Website: hc2.com

Menu

HCHC HCHC Quote HCHC Short HCHC News HCHC Articles HCHC Message Board
Get HCHC Alerts

News, Short Squeeze, Breakout and More Instantly...

HCHC - MG Capital Encourages Stockholders to Avoid Being Misled by HC2's Attempts to Rewrite History

Believes HC2’s Attacks on MG Capital and Its World-Class Slate Represent an Attempt to Distract From the Past Six Years of Dismal Corporate Governance and Persistent Value Destruction Contends That HC2’s Recent Presentations Are Just a Compilation of Distortions ȁ...

HCHC - HC2 Holdings Sets The Record Straight As Percy Rockdale's Charade Continues

Company Shares Presentations Addressing False and Misleading Narratives Being Advanced by Percy Rockdale in an Effort to Distract Stockholders from its Short-Term and Potentially Value Destroying Agenda Percy Rockdale’s Approach: Heavy on Falsehood, Light on Facts Mr. Falco...

HCHC - MG Capital Announces ISS Supports Case for Significant Change at HC2

  Leading Proxy Advisory Firm Supports Removing CEO Philip Falcone From HC2’s Board and Expresses Concern Regarding Whether He Should Run the Company Moving Forward Recommends the Removal of Three of Five Legacy Directors From the Board: Philip Falcone, Robert Leffler and...

HCHC - HC2 Holdings Issues Statement On ISS Report

HC2 URGES STOCKHOLDERS TO OPPOSE PERCY ROCKDALE’S PROPOSALS AND AGREES WITH ISS RECOMMENDATION TO VOTE AGAINST GORZYNKSI, GREENWOOD AND HICKEY ISS Questions the Viability of Percy Rockdale’s Strategy and Highlights Percy Rockdale’s Potential Short-Term Focus Co...

HCHC - Pansend Life Sciences' Portfolio Company, R2 Technologies, Receives Additional $10 Million Equity Investment From Huadong Medicine Company Limited

NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that R2 Technologies (“R2”), a privately-held portfolio company within HC2’s Pansend Life Sciences (“Pansend”...

HCHC - HC2 Holdings Highlights Its Vision for the Future

HC2 IS EXECUTING ITS PLAN TO CREATE STOCKHOLDER VALUE Percy Rockdale’s Business Plan is Impractical, Illogical, Infeasible and Costly to Execute and Destroy HC2’s Future HC2 Recommends Stockholders Sign , Date and Promptly Return the WHITE Consent Revocatio...

HCHC - MG Capital Encourages HC2 Stockholders to Focus on Electing a Truly Independent Slate of Director Nominees with a Value-Enhancing Strategy

  Calls Into Question the Board’s Late Decision to Announce an Addition to Its “Slate of Director Nominees” at the 2020 Annual Meeting Without Yet Publicly Setting a Record Date or Meeting Date Contends the Board Failed to Adequately Disclose That Its New I...

HCHC - HC2 adds Glazer to board slate, with designs on chairman role

HC2 Holdings ( HCHC +3.1% ) has added Avram Glazer of Lancer Capital to its slate of nominees to the board. More news on: HC2 Holdings, Inc., Stocks on the move, Read more ...

HCHC - MG Capital Sets the Record Straight Following HC2's Recent Efforts to Mislead Stockholders

Issues New Presentation in Response to the Latest Chapter of HC2’s Low-Road Misinformation Campaign Encourages Stockholders to Focus on the Facts Regarding MG Capital, Our Slate, and Its Well-Received Plan Makes Clear That Michael Gorzynski Possesses the Integrity, Pe...

HCHC - HC2 Holdings Sends Letter to Stockholders Correcting Gorzynski's Smear Campaign Disguised as a Consent Solicitation

TIME FOR THE TRUTH Michael Gorzynski’s Smear Campaign Disguised as a Consent Solicitation is Full of Deceit, Gross Misrepresentations, Mischaracterizations and Unwarranted Personal Attacks on Management and the Board with Little to NO DISCLOSURE on His Limited and Opaque Inv...

Previous 10 Next 10